216 related articles for article (PubMed ID: 4735211)
1. Immunosuppression and cancer.
Penn I; Starzl TE
Transplant Proc; 1973 Mar; 5(1):943-7. PubMed ID: 4735211
[No Abstract] [Full Text] [Related]
2. Malignant disease in immunodeficient states in man.
Penn I
Recent Results Cancer Res; 1975; (52):96-106. PubMed ID: 796918
[No Abstract] [Full Text] [Related]
3. Cancer is a complication of severe immunosuppression.
Penn I
Surg Gynecol Obstet; 1986 Jun; 162(6):603-10. PubMed ID: 3520906
[TBL] [Abstract][Full Text] [Related]
4. Malignancies associated with immunosuppressive or cytotoxic therapy.
Penn I
Surgery; 1978 May; 83(5):492-502. PubMed ID: 347611
[No Abstract] [Full Text] [Related]
5. [Immunology of tumors].
Surján L
Orv Hetil; 1969 Aug; 110(31):1777-82. PubMed ID: 4898067
[No Abstract] [Full Text] [Related]
6. Immunosuppression and its complications.
Woodruff M
Proc R Soc Med; 1969 Apr; 62(4):411-6. PubMed ID: 4897833
[No Abstract] [Full Text] [Related]
7. [Immunosuppression].
Amiel JL
Minerva Med; 1970 Jul; 61(55):3022-7. PubMed ID: 5427676
[No Abstract] [Full Text] [Related]
8. Development of cancer in transplantation patients.
Penn I
Adv Surg; 1978; 12():155-91. PubMed ID: 367121
[No Abstract] [Full Text] [Related]
9. Immunosuppressive therapy. Basic concepts and recent advances.
Lergier JE
Bol Asoc Med P R; 1972 Mar; 64(3):48-52. PubMed ID: 4591450
[No Abstract] [Full Text] [Related]
10. Tumor-specific immune mechanisms.
Smith RT
N Engl J Med; 1968 Jun; 278(24):1326-31 concl. PubMed ID: 4869875
[No Abstract] [Full Text] [Related]
11. [Chemotherapy and immunosuppression].
Cleton FJ
Ned Tijdschr Geneeskd; 1977 Jan; 121(1):18-21. PubMed ID: 834323
[No Abstract] [Full Text] [Related]
12. [Bases of immunosuppression and immunostimulation including their side effects in immunopathological diseases].
Deicher H
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():773-82. PubMed ID: 612054
[No Abstract] [Full Text] [Related]
13. Immunology in neoplasia relating to diagnosis, therapy and transplantation. Immunosuppression and oncogenesis.
Cerilli J; Hattan D
Am J Clin Pathol; 1974 Aug; 62(2):218-23. PubMed ID: 4602088
[No Abstract] [Full Text] [Related]
14. Proceedings: The effect of immunosuppression on cancer.
Penn I; Starzl TE
Proc Natl Cancer Conf; 1972; 7():425-36. PubMed ID: 4587653
[No Abstract] [Full Text] [Related]
15. Immunosuppression and risk of cervical cancer.
Dugué PA; Rebolj M; Garred P; Lynge E
Expert Rev Anticancer Ther; 2013 Jan; 13(1):29-42. PubMed ID: 23259425
[TBL] [Abstract][Full Text] [Related]
16. Cancers in cyclosporine-treated vs azathioprine-treated patients.
Penn I
Transplant Proc; 1996 Apr; 28(2):876-8. PubMed ID: 8623443
[No Abstract] [Full Text] [Related]
17. Another look at immunologic surveillance.
Schwartz RS
N Engl J Med; 1975 Jul; 293(4):181-4. PubMed ID: 1094290
[No Abstract] [Full Text] [Related]
18. [Possibilities and limitations of immunosuppressive treatment].
Stobbe H
Allerg Immunol (Leipz); 1973; 19(2-4):363-79. PubMed ID: 4281637
[No Abstract] [Full Text] [Related]
19. Immunosuppression and malignant neoplasms.
Starzl TE; Penn I; Halgrimson CG
N Engl J Med; 1970 Oct; 283(17):934. PubMed ID: 4917727
[No Abstract] [Full Text] [Related]
20. [Round-table discussion on immunosuppressive agents in ophthalmology].
Arch Ophtalmol Rev Gen Ophtalmol; 1972 Jan; 32(1):75-100. PubMed ID: 4261214
[No Abstract] [Full Text] [Related]
[Next] [New Search]
